Table 1. The doping drug use, age and sex distributions of the athletes and non-athletes. |
|
Athletes
(n = 433) |
Non-athletes
(n = 450) |
Total
(n = 883) |
|
| n |
% |
n |
% |
n |
% |
| Age |
| <20 |
92 |
21.2 |
111 |
24.7 |
203 |
23.7 |
χ2 = 1.6 |
| 20-24 |
309 |
71.4 |
310 |
68.9 |
619 |
69.6 |
p > .05 |
| >24 |
32 |
7.4 |
29 |
6.4 |
61 |
6.3 |
|
| Gender |
| Men |
351 |
81.1 |
347 |
77.1 |
698 |
78.2 |
χ2 = 1.6 |
| Women |
82 |
18.9 |
103 |
22.9 |
185 |
21.8 |
p > .05 |
| Drug |
| Dp + PED |
63 |
14.5 |
8 |
1.8 |
71 |
8.0 |
χ 2 = 65.7 |
| Med Tr |
166 |
38.3 |
136 |
30.3 |
302 |
34.2 |
p > .05 |
| Never |
204 |
47.2 |
306 |
67.9 |
510 |
57.8 |
|
|
Abbreviations: Dp = Doping, PED = Performance enhancing drug, Med Tr = Medical treatment. |
|